Lehrstuhl für Geburtshilfe und Frauenheilkunde

Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer Stellungnahme der Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) zur neoadjuvanten Chemotherapie vor definitiver Radiochemotherapie bei Patientinnen mit local fortgeschrittenem Zervixkarzinom (2024) Tempfer C, Fehm T, Vordermark D, Marnitz-Schulze S, Beckmann M, Denschlag D, Brucker S, et al. Journal article Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. (2023) Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev E, et al. Journal article Usability and Perception of a Wearable-Integrated Digital Maternity Record App in Germany: User Study (2023) Nissen M, Perez CA, Jäger K, Bleher H, Flaucher M, Hübner H, Danzberger N, et al. Journal article Predicting mammographic density with linear ultrasound transducers (2023) Behrens A, Fasching P, Schwenke E, Gaß P, Häberle L, Heindl F, Heusinger K, et al. Journal article Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant (2023) Neven P, Fasching P, Chia S, Jerusalem G, De Laurentiis M, Im SA, Petrakova K, et al. Journal article Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis (2023) Cortes J, Haiderali A, Huang M, Pan W, Schmid P, Akers KG, Park JE, et al. Journal article Association of two genomic variants with HPV type-specific risk of cervical cancer (2023) Seifert F, Eisenblätter R, Beckmann J, Schürmann P, Hanel P, Jentschke M, Böhmer G, et al. Journal article PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant (2023) Degenhardt T, Fasching P, Lüftner D, Müller V, Thomssen C, Schem C, Witzel I, et al. Journal article Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy (2023) Huober J, van Mackelenbergh M, Schneeweiss A, Seither F, Blohmer JU, Denkert C, Tesch H, et al. Journal article Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry (2023) Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, et al. Journal article